Credit: TB Europe CoalitionThe TB Europe Coalition released a report summarizing the findings of a 2024 community-led monitoring (CLM) initiative that assessed the procurement processes for shorter TB treatment regimens in four Eastern Europe and Central Asia (EECA) countries over the 2022–2024 period.
As a mechanism ensuring independent oversight and community engagement, the CLM focused on evaluating the current status of access to and availability of the latest shorter TB treatment regimens, as well as identifying existing gaps in Kyrgyzstan, Moldova, Tajikistan, and Ukraine.
The assessment covered national legislation and international procurement mechanisms and projects related to TB drugs for shorter treatment regimens. This included funding and procurement volumes, international nonproprietary names, quantities, prices, and manufacturers. Interviews were also conducted with specialists from the national TB programs’ pharmaceutical and statistical units.
Access the report here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #21, 30 June 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and EATG. Subscribe to the newsletter here.
Source : TB Europe Coalition
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.